Appiah John K, Asante Richeal, Asiedu Emmanuel K
Internal Medicine, Geisinger Health System, Wilkes-Barre, USA.
Internal Medicine, Mother and Child Hospital, Accra, GHA.
Cureus. 2025 May 26;17(5):e84847. doi: 10.7759/cureus.84847. eCollection 2025 May.
Introduction Colorectal cancer (CRC) remains a leading cause of cancer-related mortality in the United States. While overall mortality has declined due to improvements in screening and treatment, persistent disparities by race, sex, and geography raise concerns about equitable healthcare access. Objective The objective of the study is to assess long-term trends in CRC mortality in the United States from 2000 to 2020, with a focus on racial, sex-based, and geographic disparities. Materials and methods A retrospective observational study was conducted using data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) database. CRC mortality was identified using International Classification of Diseases, 10th Revision (ICD-10) codes C18-C21. Data were stratified by race, sex, and U.S. state. Age-adjusted death rates per 100,000 population were calculated and averaged over the 20-year period. Poisson regression analysis was conducted to assess the independent association of race and sex with mortality. Results were visualized by subgroup and geographic distribution. Results Black men had the highest national CRC mortality rate (17.7/100,000), followed by White men (15.3/100,000). Men consistently experienced higher mortality than women across all racial groups. Asian/Pacific Islander and American Indian or Alaska Native (AI/AN) populations had the lowest age-adjusted rates. Southern and Midwestern states demonstrated the highest average state-level mortality rates. Poisson regression confirmed that White (rate ratio (RR): 2.46), Black (RR: 2.24), and Asian (RR: 1.13) individuals had higher mortality than AI/AN individuals. Men had 9.2% higher mortality than women (RR: 1.09). All results were statistically significant (p < 0.001). Conclusion Significant disparities in CRC mortality persist across racial, sex, and regional lines in the United States. Black men experience the highest age-adjusted mortality, and overall rates are consistently higher among men than women. States in the South and Midwest carry the greatest burden, underscoring the need for geographically targeted interventions. These findings highlight the urgency of expanding access to screening, addressing systemic inequities, and implementing risk-based public health strategies in underserved communities.
引言
在美国,结直肠癌(CRC)仍然是癌症相关死亡的主要原因。尽管由于筛查和治疗的改善,总体死亡率有所下降,但种族、性别和地域方面持续存在的差异引发了人们对医疗保健公平可及性的担忧。
目的
本研究的目的是评估2000年至2020年美国结直肠癌死亡率的长期趋势,重点关注种族、性别和地域差异。
材料与方法
使用美国疾病控制与预防中心广泛在线流行病学研究数据(CDC WONDER)数据库中的数据进行了一项回顾性观察研究。通过国际疾病分类第十版(ICD-10)编码C18-C21确定结直肠癌死亡率。数据按种族、性别和美国州进行分层。计算每10万人口的年龄调整死亡率,并在20年期间进行平均。进行泊松回归分析以评估种族和性别与死亡率的独立关联。结果按亚组和地理分布进行可视化展示。
结果
黑人男性的全国结直肠癌死亡率最高(17.7/10万),其次是白人男性(15.3/10万)。在所有种族群体中,男性的死亡率始终高于女性。亚洲/太平洋岛民和美国印第安人或阿拉斯加原住民(AI/AN)群体的年龄调整率最低。南部和中西部各州的州级平均死亡率最高。泊松回归证实,白人(率比(RR):2.46)、黑人(RR:2.24)和亚洲人(RR:1.13)的死亡率高于AI/AN群体。男性的死亡率比女性高9.2%(RR:1.09)。所有结果均具有统计学意义(p<0.001)。
结论
在美国,结直肠癌死亡率在种族、性别和地区方面存在显著差异。黑人男性的年龄调整死亡率最高,总体上男性的死亡率始终高于女性。南部和中西部各州负担最重,这突出了针对不同地区采取干预措施的必要性。这些发现凸显了在服务不足的社区扩大筛查可及性、解决系统性不平等问题以及实施基于风险的公共卫生策略的紧迫性。